UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Risk factors and incidence of long-COVID syndrome in hospitalized patients: does remdesivir have a protective effect?

QJM : An International Journal of Medicine, 2022-01, Vol.114 (12), p.865-871

2022

Volltextzugriff (PDF)

Pharmacogenetics of tenofovir drug transporters in the context of HBV: Is there an impact?

Biomedicine & pharmacotherapy, 2024-06, Vol.175, p.116678, Article 116678

2024

Volltextzugriff (PDF)

Treatment with direct‐acting antiviral agents of hepatitis C virus infection in injecting drug users: A prospective study

Journal of viral hepatitis, 2017-10, Vol.24 (10), p.850-857

2017

Volltextzugriff (PDF)

Role of CYP27B1+2838 promoter polymorphism in the treatment of chronic hepatitis B HBeAg negative with PEG-interferon

Journal of viral hepatitis, 2015-03, Vol.22 (3), p.318-327

2015

Volltextzugriff (PDF)

Sequential therapy with entecavir and peginterferon alpha in chronic hepatitis B: for many but not for all?

Journal of viral hepatitis, 2016-05, Vol.23 (5), p.402-403

2016

Volltextzugriff (PDF)

Significant early higher ribavirin plasma concentrations in patients receiving a triple therapy with pegylated interferon, ribavirin and telaprevir

Journal of viral hepatitis, 2014-04, Vol.21 (4), p.260-263

2014

Volltextzugriff (PDF)

Sequential therapy with entecavir and PEG-INF in patients affected by chronic hepatitis B and high levels of HBV-DNA with non-D genotypes

Journal of viral hepatitis, 2013-04, Vol.20 (4), p.e11-e19

2013

Volltextzugriff (PDF)

HCV NS3 naturally occurring variants in HIV/HCV coinfected DAA-naïve patients: consideration for HCV genotyping resistance testing

Infection, 2016-12, Vol.44 (6), p.789-792

2016

Volltextzugriff (PDF)

Relationship between the early Boceprevir-S isomer plasma concentrations and the onset of breakthrough during HCV genotype 1 triple therapy

Clinical microbiology and infection, 2015-02, Vol.21 (2), p.205.e1-205.e3

2015

Volltextzugriff (PDF)

Higher simeprevir plasma exposure when co-administered with sofosbuvir leads to higher risk of dermatological toxicity

Digestive and liver disease, 2016-02, Vol.48, p.e58-e58

2016

Volltextzugriff (PDF)

Treatment of high baseline viral load chronic hepatitis B using sequential therapy with entecavir and PEG-IFN

Digestive and liver disease, 2016-02, Vol.48, p.e56-e56

2016

Volltextzugriff (PDF)

Are detectable sofosbuvir trough concentrations predictive of virological failure during anti-HCV treatment? Preliminary evidences from the KINETI-C study

Digestive and liver disease, 2017-02, Vol.49 (1), p.e61-e61

2017

Volltextzugriff (PDF)

The challenge of HCV-retreatment after DAA-failure: real-life experience advocates for caution

Journal of hepatology, 2017, Vol.66 (1), p.S744-S745

2017

Volltextzugriff (PDF)

P1187 A CONCENTRATION-DEPENDENT PHARMACOKINETIC INTERACTION WITH TELAPREVIR INCREASES RIBAVIRIN CONCENTRATIONS AND LEADS TO HIGHER HAEMOGLOBIN DROP

Journal of hepatology, 2014-04, Vol.60 (1), p.S482-S482

2014

Volltextzugriff (PDF)

Unifying interpretation of reflection coefficient and Smith chart definitions

IET microwaves, antennas & propagation, 2011-09, Vol.5 (12), p.1479-1487

2011

Volltextzugriff (PDF)

An unusual case of colonic occlusion

European journal of surgical oncology, 2012-10, Vol.38 (10), p.1002-1002

2012

Volltextzugriff (PDF)

The challenge of HCV-retreatment after DAA-failure: Italian real-life from VIRONET-C network

Digestive and liver disease, 2017-02, Vol.49 (1), p.e8-e8

2017

Volltextzugriff (PDF)

Two cases of gallbladder metastases

European journal of surgical oncology, 2012-10, Vol.38 (10), p.990-991

2012

Volltextzugriff (PDF)

The co-administration of telaprevir increases ribavirin plasma and intra-erythrocytic concentrations, causing higher onset of anemia

Digestive and liver disease, 2014-02, Vol.46, p.e10-e10

2014

Volltextzugriff (PDF)

F-33 Early ribavirin plasma concentration and ITPA polymorphisms as determinants of anemia after one month of anti-HCV therapy

Digestive and liver disease, 2012-02, Vol.44, p.S42-S42

2012

Volltextzugriff (PDF)

Guest Editorial

IEEE transactions on microwave theory and techniques, 2008-05, Vol.56 (5), p.1217

Boglione, L

2008

Volltextzugriff (PDF)

Virological response and safety in a cohort of immigrant patients affected by chronic hepatitis delta treated with PEG-IFN

Journal of hepatology, 2018-04, Vol.68, p.S525-S526

2018

Volltextzugriff (PDF)

FRI-361 - Virological response and safety in a cohort of immigrant patients affected by chronic hepatitis delta treated with PEG-IFN

Journal of hepatology, 2018-04, Vol.68, p.S525-S526

2018

Volltextzugriff (PDF)

An Original Demonstration of the [Formula Omitted] Inequality for Noisy Two-Port Networks

IEEE microwave and wireless components letters, 2008-05, Vol.18 (5), p.326-328

Boglione, L

2008

Volltextzugriff (PDF)

FRI-275 - Role of hepatitis B core-related antigen and antibodies to hepatitis B core antigen level in the natural history of chronic HBV infection

Journal of hepatology, 2018-04, Vol.68, p.S483-S483

2018

Volltextzugriff (PDF)

1 – 25 von 140

Suche als RSS-Feed

Aktive Filter

KollektionJSTOR

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(130)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(84)
Engineering
(54)
Engineering, Electrical & Electronic
(54)
Technology
(54)
Telecommunications
(47)
Life Sciences & Biomedicine
(26)
Radio Frequency
(21)
Humans
(20)
Male
(14)
Female
(13)
Adult
(11)
Middle Aged
(11)
Linearity
(10)
Noise Figure
(10)
Frequency
(9)
Heterojunction Bipolar Transistors
(9)
Silicon
(9)
Circuits
(8)
Gastroenterology And Hepatology
(8)
Infectious Diseases
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Risk factors and incidence of long-COVID syndrome in hospitalized patients: does remdesivir have a protective effect?

Pharmacogenetics of tenofovir drug transporters in the context of HBV: Is there an impact?

Treatment with direct‐acting antiviral agents of hepatitis C virus infection in injecting drug users: A prospective study

Role of CYP27B1+2838 promoter polymorphism in the treatment of chronic hepatitis B HBeAg negative with PEG-interferon

Sequential therapy with entecavir and peginterferon alpha in chronic hepatitis B: for many but not for all?

Significant early higher ribavirin plasma concentrations in patients receiving a triple therapy with pegylated interferon, ribavirin and telaprevir

Sequential therapy with entecavir and PEG-INF in patients affected by chronic hepatitis B and high levels of HBV-DNA with non-D genotypes

HCV NS3 naturally occurring variants in HIV/HCV coinfected DAA-naïve patients: consideration for HCV genotyping resistance testing

Relationship between the early Boceprevir-S isomer plasma concentrations and the onset of breakthrough during HCV genotype 1 triple therapy

Higher simeprevir plasma exposure when co-administered with sofosbuvir leads to higher risk of dermatological toxicity

Treatment of high baseline viral load chronic hepatitis B using sequential therapy with entecavir and PEG-IFN

Are detectable sofosbuvir trough concentrations predictive of virological failure during anti-HCV treatment? Preliminary evidences from the KINETI-C study

The challenge of HCV-retreatment after DAA-failure: real-life experience advocates for caution

P1187 A CONCENTRATION-DEPENDENT PHARMACOKINETIC INTERACTION WITH TELAPREVIR INCREASES RIBAVIRIN CONCENTRATIONS AND LEADS TO HIGHER HAEMOGLOBIN DROP

Unifying interpretation of reflection coefficient and Smith chart definitions

An unusual case of colonic occlusion

The challenge of HCV-retreatment after DAA-failure: Italian real-life from VIRONET-C network

Two cases of gallbladder metastases

The co-administration of telaprevir increases ribavirin plasma and intra-erythrocytic concentrations, causing higher onset of anemia

F-33 Early ribavirin plasma concentration and ITPA polymorphisms as determinants of anemia after one month of anti-HCV therapy

Guest Editorial

Virological response and safety in a cohort of immigrant patients affected by chronic hepatitis delta treated with PEG-IFN

FRI-361 - Virological response and safety in a cohort of immigrant patients affected by chronic hepatitis delta treated with PEG-IFN

An Original Demonstration of the [Formula Omitted] Inequality for Noisy Two-Port Networks

FRI-275 - Role of hepatitis B core-related antigen and antibodies to hepatitis B core antigen level in the natural history of chronic HBV infection

Aktive Filter

Suchergebnisse filtern